Insider filing · MNPR
Christopher M Starr
Director
profile →
Monopar Therapeutics Inc.
MNPR · Healthcare · 14 filings in 24 months
ticker →
Christopher M Starr sold $596K of Monopar Therapeutics (MNPR)
Executed Oct 1, disclosed Oct 5, 4 days later.
Value, as filed
$596K
7,601 sh across 2 lots
Executed
Oct 1
the trade date, as filed
Disclosed
Oct 5
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CSChristopher M Starr (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Monopar Therapeutics Inc. (MNPR). The largest single filing was $596K of MNPR (7,601 sh across 2 lots, as filed), executed Oct 1.
The name
MNPRHealthcare · Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Christopher M Starr in MNPR
MNPRSALE
Monopar Therapeutics Inc.
$672K16,800 sh × $40.00
Exec Jul 14 2025
Filed Jul 16 2025 · 5:30 PM ET